← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA8658.0x12.7x19.5x
EV / LTM revenue12700.7x1.6x3.5x
Premium to unaffected price115920%32%52%
Premium to 30-day VWAP22116%34%48%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
0901792009: 11 deals, 2 clean on every measure2009112010: 179 deals, 40 clean on every measure20101792011: 164 deals, 92 clean on every measure20111642012: 133 deals, 117 clean on every measure20121332013: 155 deals, 136 clean on every measure20131552014: 98 deals, 85 clean on every measure2014982015: 121 deals, 108 clean on every measure20151212016: 156 deals, 142 clean on every measure20161562017: 120 deals, 109 clean on every measure20171202018: 127 deals, 113 clean on every measure20181272019: 115 deals, 108 clean on every measure20191152020: 87 deals, 73 clean on every measure2020872021: 119 deals, 99 clean on every measure20211192022: 112 deals, 98 clean on every measure20221122023: 108 deals, 86 clean on every measure20231082024: 133 deals, 109 clean on every measure20241332025: 121 deals, 98 clean on every measure20251212026: 62 deals, 52 clean on every measure202662
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 18.4x median across 84 dealsHealthcare18.4xn=84Technology: 16.7x median across 170 dealsTechnology16.7xn=170Real Estate: 16.2x median across 51 dealsReal Estate16.2xn=51Business Services: 12.8x median across 74 dealsBusiness Services12.8xn=74Industrials: 12.7x median across 116 dealsIndustrials12.7xn=116Financials: 12.7x median across 25 dealsFinancials12.7xn=25Utilities: 12.1x median across 58 dealsUtilities12.1xn=58Consumer & Retail: 10.3x median across 141 dealsConsumer & Retail10.3xn=141Materials: 9.6x median across 40 dealsMaterials9.6xn=40Other: 9.5x median across 31 dealsOther9.5xn=31Media & Telecom: 9.3x median across 41 dealsMedia & Telecom9.3xn=41Energy: 8.5x median across 34 dealsEnergy8.5xn=34
Deals by sector
Technology: 421 dealsTechnology421Healthcare: 315 dealsHealthcare315Consumer & Retail: 245 dealsConsumer & Retail245Industrials: 234 dealsIndustrials234Financials: 216 dealsFinancials216Business Services: 155 dealsBusiness Services155Real Estate: 142 dealsReal Estate142Media & Telecom: 85 dealsMedia & Telecom85Energy: 82 dealsEnergy82Utilities: 79 dealsUtilities79Materials: 78 dealsMaterials78Other: 69 dealsOther69
Deals by buyer type
Financial sponsor: 123 dealsFinancial sponsor123Strategic: 1073 dealsStrategic1073Management / founder: 2 dealsManagement / founder2Controlling holder: 10 dealsControlling holder10Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 913 dealsUnclassified913
Deals by enterprise value
Under $250m: 809 dealsUnder $250m809$250m to $1bn: 489 deals$250m to $1bn489$1bn to $5bn: 538 deals$1bn to $5bn538$5bn to $20bn: 211 deals$5bn to $20bn211Over $20bn: 31 dealsOver $20bn31Not computed: 43 dealsNot computed43
Deals by industry code
Business Services & Software: 390 dealsBusiness Services & Sof…390Chemicals, Pharmaceuticals & Allied Products: 204 dealsChemicals, Pharmaceutic…204Electronics & Electrical Equipment: 149 dealsElectronics & Electrica…149Instruments, Medical Devices & Optical Goods: 109 dealsInstruments, Medical De…109Holding & Other Investment Offices: 96 dealsHolding & Other Investm…96Electric, Gas & Sanitary Services: 79 dealsElectric, Gas & Sanitar…79Insurance Carriers: 72 dealsInsurance Carriers72Industrial Machinery & Computers: 69 dealsIndustrial Machinery & …69Health Services: 69 dealsHealth Services69Communications: 65 dealsCommunications65
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
Symmetry Medical Inc.
2014-08-04 · Public merger · $7.50 a share
TecoStar Holdings, Inc.
Strategic
Healthcare$434mn.a.1.1x
n.a.
DEFM14A
All cash
Bally Technologies, Inc.
2014-08-01 · Public merger · $83.30 a share
Scientific Games Corporation
Strategic
Technology$5.1bn14.2x4.2x
38%
DEFM14A
All cash
Le Gaga Holdings Ltd
2014-07-30 · Take-private · $0.08 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Not named in the filing
Unclassified
Other$179mn.a.n.a.
22%
13% to VWAP
SC 13E3
All cash
Sunway Global Inc.
2014-07-30 (filed) · Take-private · $0.18 a share
Not named in the filing
Unclassified
Industrials$2mn.a.0.3x
n.a.
71% to VWAP
SC 13E3
All cash
QR Energy, LP
2014-07-23 · Public merger · $21.62 a share
Breitburn Energy Partners LP
Strategic
Energy$1.3bn5.3x2.6x
25%
DEFM14A
All cash
Asia Green Agriculture Corp
2014-06-25 (filed) · Take-private · $0.60 a share
Not named in the filing
Unclassified
Other$40m1.1x0.3x
30%
31% to VWAP
SC 13E3
All cash
Medical Action Industries Inc
2014-06-24 · Public merger · $13.80 a share
Owens & Minor, Inc.
Strategic
Healthcare$306m36.9x1.1x
n.a.
DEFM14A
All cash
First Physicians Capital Group, Inc.
2014-06-20 (filed) · Take-private · $0.55 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Not named in the filing
Unclassified
Healthcare$4mn.a.n.a.
n.a.
SC 13E3
All cash
Measurement Specialties Inc
2014-06-18 · Public merger · $86.00 a share
TE Connectivity Ltd.
Strategic
Industrials$1.3bn19.0xn.a.
n.a.
DEFM14A
All cash
Equal Energy Ltd.
2014-06-11 (filed) · Public merger · $5.43 a share
Not named in the filing
Unclassified
Energy$179mn.a.2.5x
n.a.
DEFM14A
All cash
Protective Life Corp
2014-06-03 · Public merger · $70.00 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
DL Investment, Inc.
Financial sponsor
Financials$5.5bn9.9x1.3x
34%
DEFM14A
All cash
PetroLogistics LP
2014-05-27 · Public merger · $14.00 a share
GP Holdings
Strategic
Healthcare$2.3bn9.7x3.0x
n.a.
DEFM14C
All cash
'mktg, inc.'
2014-05-27 · Public merger · $2.80 a share
Held out of the premiums: premium of 166%: distressed or misread
Not named in the filing
Unclassified
Business Services$15m4.1xn.a.
166%
DEFM14A
All cash
Charm Communications Inc.
2014-05-23 · Take-private · $2.35 a share
Engadin Parent Limited
Unclassified
Business Services$70m15.6x0.4x
n.a.
SC 13E3
All cash
Aeroflex Holding Corp.
2014-05-19 · Public merger · $10.50 a share
Not named in the filing
Unclassified
Technology$1.4bn74.3x2.3x
27%
DEFM14A
All cash
Hancock Fabrics Inc
2014-05-09 (filed) · Take-private · $1.20 a share
Not named in the filing
Unclassified
Consumer & Retail$106m12.8x0.4x
n.a.
13% to VWAP
SC 13E3
All cash
SP Bancorp, Inc.
2014-05-05 · Public merger · $29.55 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Not named in the filing
Unclassified
Financials$47mn.a.n.a.
44%
DEFM14A
All cash
Barry R G Corp /Oh/
2014-05-01 · Public merger · $19.00 a share
MRGB Hold Co.
Strategic
Consumer & Retail$191m9.3xn.a.
n.a.
DEFM14A
All cash
Pokertek, Inc.
2014-04-29 · Public merger · $1.35 a share
Held out of the multiples: EV / LTM EBITDA 122.0x outside 1x to 75x
Multimedia Games, Inc.
Strategic
Other$12m122.0x2.3x
37%
DEFM14A
All cash
Furiex Pharmaceuticals, Inc.
2014-04-27 · Public merger · $95.00 a share
Forest Laboratories, Inc.
Strategic
Healthcare$1.0bnn.a.27.0x
19%
DEFM14A
All cash
Belk Inc
2014-04-24 (filed) · Take-private · $48.10 a share
Not named in the filing
Unclassified
Consumer & Retail$2.1bn4.9x0.5x
n.a.
SC 13E3
All cash
Cbeyond, Inc.
2014-04-19 · Public merger · $10.00 a share
Birch Communications, Inc.
Strategic
Media & Telecom$301m5.1x0.7x
41%
DEFM14A
All cash
Chindex International Inc
2014-04-18 · Public merger · $24.00 a share
Healthy Harmony Holdings, L.P.
Strategic
Industrials$439m43.9x2.7x
40%
DEFM14A
All cash
Chindex International Inc
2014-04-18 · Take-private · $24.00 a share
Healthy Harmony Holdings, L.P.
Strategic
Industrials$29m2.9x0.2x
40%
SC 13E3
All cash
iSoftStone Holdings Ltd
2014-04-18 · Take-private · $0.57 a share
New iSoftStone Holdings Limited
Strategic
Technology$351m17.1x0.8x
18%
SC 13E3
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More